{"disease":{"id":"platinum-responsive-malignancies","name":"platinum responsive malignancies"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT01110226","title":"Trial Of Cisplatin And KML-001 in Platinum Responsive Malignancies","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":23,"lead_sponsor_name":"University of Maryland, Baltimore","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}